Taaleri Bioteollisuus

Taaleri Bioindustry invests in C2CA, a company upcycling waste concrete

Share

TAALERI BIOINDUSTRY          PRESS RELEASE          13 NOVEMBER 2024 AT 9:07 (EET)

Taaleri Bioindustry invests in C2CA, a company upcycling waste concrete

Taaleri Bioindustry Fund I is investing in C2CA Technology B.V., a Duch company and the technological leader in waste concrete upcycling. The investment will enable the construction of a full-scale commercial production facility in Rotterdam, in the Netherlands. The factory will process approximately 150,000 tonnes of waste concrete annually.

C2CA has developed a process that allows upcycling of end-of-life concrete into drop-in materials for use in new concrete. The innovative process enables the effective separation of the individual components of end-of-life concrete (aggregate, sand and cement paste) through the combination of mechanical and thermal processes. C2CA's upcycled materials have been used in six reference construction projects under the Dutch Climate Envelope initiative, showcasing their quality and performance in real-world applications.

The company’s economic activities contribute significantly to the climate objectives of the EU Taxonomy by enabling the upcycling of 100% of end-of-life concrete, and reducing emissions compared to conventional concrete mix by 20–30% according to a third-party verified life cycle assessment. The economic activities of C2CA are taxonomy eligible and aligned in the categories “Manufacture of Cement” and “Material recovery from non-hazardous waste”.

The investment is Taaleri Bioindustry Fund I’s fifth investment. The fund invests in industrial-scale production facilities and companies that can accelerate the expansion of bioindustry production, circular economy initiatives and renewable energy solutions (excluding wind, solar and battery storage plants).

Taaleri Bioindustry Fund I complies with Article 9 of the EU Sustainable Finance Disclosure Regulation and therefore makes only sustainable investments in companies that, for example, contribute substantially to climate change mitigation. The fund has raised over EUR 100 million in commitments.

“We are thrilled to begin cooperation with C2CA. The company provides an excellent example of a circular economy solution where the material recovery is exceptional. This reduces the need for virgin raw materials, thereby providing lower carbon-footprint materials for the construction industry. This proven, ready-to-scale technology presents an opportunity to make a notable environmental impact while creating value for customers,” says Tero Saarno, Director (Investments and Projects) of Taaleri Bioindustry.

“Thanks to this investment and with the continued support of our owners, we will be able to deliver high-quality, low-carbon alternatives to traditional concrete materials – sourced from local demolition projects and supplied to local concrete producers. This decentralised approach is a paradigm shift in the industry, and our holistic approach ensures a validated reduction in environmental impact, cost savings and happy customers,” C2CA says.

For further information, please contact:

Tero Saarno, Director (Investments and Projects), Taaleri Bioindustry, +358 50 373 1923, tero.saarno@taaleri.com

Taaleri in brief

Taaleri is a Nordic investment and asset manager that focuses on businesses with industrial-scale opportunities within bioindustry and renewable energy. We create value by combining extensive know-how, deep expertise, entrepreneurship and capital through both funds under management and direct investments. We have been a signatory of the UN Principles for Responsible Investment (UNPRI) since 2010, and we joined the Net Zero Asset Managers initiative in 2021. Taaleri’s vision is to become a leading investment manager operating internationally in bioindustry and renewable energy.  

Taaleri has EUR 2.6 bn of assets under management in its private equity funds and co-investments. The company has approximately 130 employees. Taaleri Plc is listed on Nasdaq Helsinki.  

www.taaleribioindustry.com

C2CA Technology B.V. in brief

As the technological leader in waste concrete upcycling, C2CA Technology B.V. makes upcycling a practical, profitable and sustainable choice. Their groundbreaking technology produces low-carbon concrete by transforming waste into high-performing substitute materials, providing a clear path to a sustainable competitive advantage.

www.c2ca.tech

Alternative languages

Subscribe to releases from Taaleri Bioteollisuus

Subscribe to all the latest releases from Taaleri Bioteollisuus by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Taaleri Bioteollisuus

Taalerin bioteollisuusrahasto sijoittaa sieniproteiinia valmistavaan Eniferiin23.5.2024 08:45:00 EEST | Tiedote

TAALERI BIOTEOLLISUUS LEHDISTÖTIEDOTE 23.5.2024 KLO 8.45 Taalerin bioteollisuusrahasto sijoittaa sieniproteiinia valmistavaan Eniferiin Taalerin bioteollisuuteen keskittyvä Bioteollisuus I -rahasto sijoittaa suomalaiseen sieni- eli mykoproteiinia valmistavaan Eniferiin. Sijoitus mahdollistaa uuden tuotantolaitoksen rakentamisen Kantvikiin Kirkkonummelle. Enifer perustettiin vuonna 2020 patentoidun PEKILO®-teknologian jatkokehittämistä ja kaupallistamista varten. Mykoproteiinin valmistuksessa hyödynnetään fermentointiprosessia, joka kehitettiin Suomessa alun perin 1970-luvulla. Nykyinen valmistustapa muistuttaa oluen tai soijan fermentointiprosessia. Eniferin mykoproteiini on kestävä vaihtoehto eläin- ja kasviproteiineille. Vaihtoehtoinen proteiininlähde edesauttaa biodiversiteetin säilymistä, sillä tuotanto ei vaadi maankäyttöä ja lisää sitä epäsuorasti vain vähän. Enifernin mykoproteiinilla on matala hiili- ja vesijalanjälki verrattuna eläin- ja kasviproteiineihin. PEKILO®-mykoproteii

Taaleri’s bioindustry fund invests in Enifer, a company producing mycoprotein23.5.2024 08:45:00 EEST | Press release

TAALERI BIOINDUSTRY PRESS RELEASE 23 MAY 2024 AT 8:45 (EEST) Taaleri’s bioindustry fund invests in Enifer, a company producing mycoprotein Taaleri Bioindustry Fund I invests in Enifer, a Finnish company producing fungi-based mycoprotein. Investment enables Enifer to construct a new mycoprotein factory in Kantvik, Kirkkonummi, Finland. Enifer was founded in 2020 to develop and commercialize the proprietary PEKILO® technology further. Mycoprotein is produced by cultivating a specific species of fungus in a fermentation process that is not too distinct from brewing beer or making soy sauce. The PEKILO® fermentation process was originally developed in Finland in the 1970s and used by the forest industry. Mycoprotein is a sustainable alternative to animal and some soy proteins. This alternative protein has a significant positive contribution to biodiversity because the production process does not require direct land use as many other plant and animal proteins do. The production of mycoprote

Taaleri’s bioindustry fund invests in Nordic Bioproducts Group, a company producing cellulose-based materials with a high processing value30.3.2023 09:15:00 EEST | Press release

TAALERI BIOINDUSTRY PRESS RELEASE 30 MARCH 2023 AT 9:15 (EEST) Taaleri’s bioindustry fund invests in Nordic Bioproducts Group, a company producing cellulose-based materials with a high processing value Taaleri’s bioindustry fund invests in Nordic Bioproducts Group, a Finnish company producing cellulose-based materials with a high processing value. The purpose of the investment is to strengthen Nordic Bioproducts Groups’s (NBG) growth and expansion. Nordic Bioproducts Group was founded in 2019 to develop new biomaterials based on the patented AaltoCell technology. The cellulose hybrids developed and manufactured by NBG are processed from Finnish forest fibres and cellulose-containing industrial and agricultural side and waste streams. The company aims to bring to the market environmentally more sustainable and low-emissions alternatives to fossil raw materials and harmful chemicals. For example, in the textile industry, pulp-based fibres can replace cotton and artificial fibres, and in

Taalerin bioteollisuusrahasto sijoittaa korkean jalostusarvon selluloosapohjaisia materiaaleja valmistavaan Nordic Bioproducts Groupiin30.3.2023 09:15:00 EEST | Tiedote

TAALERI BIOTEOLLISUUS LEHDISTÖTIEDOTE 30.3.2023 klo 9.15 Taalerin bioteollisuusrahasto sijoittaa korkean jalostusarvon selluloosapohjaisia materiaaleja valmistavaan Nordic Bioproducts Groupiin Taalerin bioteollisuuteen keskittyvä rahasto Taaleri Bioteollisuus I sijoittaa suomalaiseen korkean jalostusarvon selluloosapohjaisia materiaaleja valmistavaan Nordic Bioproducts Groupiin. Sijoituksella on tarkoitus vahvistaa Nordic Bioproducts Groupin (NBG) kasvua ja laajentumista. Nordic Bioproducts Group perustettiin vuonna 2019 kehittämään uusia biomateriaaleja, jotka perustuvat patentoituun AaltoCell-teknologiaan. NBG:n kehittämät ja valmistamat selluloosahybridit on jalostettu kotimaisista metsäkuiduista sekä selluloosaa sisältävistä teollisuuden ja maatalouden sivu- ja jätevirroista. Yhtiö pyrkii tuomaan markkinoille ympäristön kannalta kestävämpiä ja vähäpäästöisempiä vaihtoehtoja fossiilisille raaka-aineille ja haitallisille kemikaaleille. Esimerkiksi tekstiiliteollisuudessa sellupohjais

Taaleri’s first bioindustry fund invests in Nordtreat, a company producing bio-based flame retardants22.11.2022 09:15:00 EET | Press release

TAALERI BIOINDUSTRY PRESS RELEASE 22 NOVEMBER 2022 AT 9:15 (EET) Taaleri’s first bioindustry fund invests in Nordtreat, a company producing bio-based flame retardants Taaleri’s first bioindustry fund invests in Nordtreat, a Finnish company producing bio-based, environmentally friendly and non-harmful flame-retardants. The purpose of the investment is to strengthen Nordtreat's growth and expansion. Founded in 2015, Nordtreat manufactures bio-based flame-retardant chemicals for building materials made from renewable raw materials. The company has developed and commercialized fire retardants, especially for wood construction. The products are based on the company's patented fire protection technology. Nordtreat's products replace traditional flame-retardants that contain compounds that are harmful to humans and the environment, such as boric acid, formaldehyde, and ammonia. The investment is Taaleri Bioindustry I Fund’s second investment. The fund invests in industrial-scale production fa

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye